Condition
Interstitial Lung Disease in Patients With Rheumatoid Arthritis
Total Trials
5
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Enrolling By Invitation2
Unknown1
Not Yet Recruiting1
Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07363980Enrolling By Invitation
Coronary Computed Tomography Angiography In Rheumatoid Arthritis Study
NCT06965322Recruiting
Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis
NCT07217093Not Yet Recruiting
Teleconsultation Approach to CTD-ILD Care Delivery in Rural UnderServed CommuniTies (TRUST Initiative)
NCT07061873Not ApplicableEnrolling By Invitation
Physical Exercise Program for Adults With Diffuse Interstitial Lung Disease in a Pulmonary Rehabilitation Context
NCT04356066Not ApplicableUnknownPrimary
CXCL10 As a Biomarker Of ILD in Patients WithRA
Showing all 5 trials